Type I insulin dependent diabetes: an autoimmune disease that can be arrested or prevented with immunotherapy?
D001323:Autoantibodies / Q000276:immunology; D001327:Autoimmune Diseases / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D002648:Child; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D015803:HLA-DR3 Antigen; D015804:HLA-DR4 Antigen; D000949:Histocompatibility Antigens Class II / Q000235:genetics; D006801:Humans; D007167:Immunotherapy; D008954:Models, Biological
D001323:Autoantibodies; D003524:Cyclosporins; D015803:HLA-DR3 Antigen; D015804:HLA-DR4 Antigen; D000949:Histocompatibility Antigens Class II; C024211:islet cell antibody